The World Health Organization announced Monday that it was pausing an ongoing trial of how hydroxychloroquine impacts hospitalized COVID-19 patients over safety concerns of the anti-malaria drug—medicine that President Donald Trump said he was taking for at least two weeks.
Trending:
WHO pauses hydroxychloroquine trial amid safety concerns day after Trump says he stopped taking controversial medicine